Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is labeled Phase NA and is studying how a brain stimulation technique called neuromodulation affects white matter and connectivity in schizophrenia — what does it mean that there's no traditional drug phase here, and what is actually known so far about whether this type of brain stimulation is safe for people with schizophrenia?
2. 2The trial is measuring things like white matter fractional anisotropy and resting-state functional connectivity using MRI and fMRI — can you explain in plain terms what those measurements tell us, and how would changes in those brain scans actually translate to any difference in how I feel or function day to day?
3. 3Since this study seems to be focused on understanding brain changes rather than directly testing a new treatment for symptoms, would participating in it affect my current medication plan or standard care in any way?
4. 4Given that the trial involves MRI and fMRI scans alongside neuromodulation sessions, how many visits would be required and how long does each session typically take — and is that kind of commitment realistic given my current situation?
5. 5Are there other options I should consider first, like optimizing my current medications or other established therapies, before deciding whether joining a research study focused on brain connectivity measurements makes sense for me right now?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.